6929 logo

We Can Medicines Co., Ltd. Stock Price

TPEX:6929 Community·NT$1.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6929 Share Price Performance

NT$0
-39.10 (-100.00%)
NT$0
-39.10 (-100.00%)
Price NT$0

6929 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

2 Risks
1 Reward

We Can Medicines Co., Ltd. Key Details

NT$3.2b

Revenue

NT$2.2b

Cost of Revenue

NT$1.1b

Gross Profit

NT$1.1b

Other Expenses

-NT$79.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.76
32.96%
-2.46%
11.6%
View Full Analysis

About 6929

Founded
1972
Employees
1005
CEO
De-Lan Wen
WebsiteView website
www.yourchance.com.tw

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and infant product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

Recent 6929 News & Updates

Recent updates

No updates